Lv21
200 积分 2024-07-20 加入
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
2小时前
已完结
Thymocyte selection‐associated high mobility box protein regulates T lymphocytes exhaustion in patients with myelodysplastic syndromes by inhibiting PI3K/AKT/mTOR pathway
3个月前
已完结
Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients
3个月前
已完结
Chemotaxis-driven hybrid liposomes recover intestinal homeostasis for targeted colitis therapy
4个月前
已完结
Real world efficacy of luspatercept in patients with lower-risk myelodysplastic syndromes/neoplasms (MDS); a single center study in a heavily pretreated cohort
4个月前
已完结
PI3k/AKT signaling pathway: Erythropoiesis and beyond
5个月前
已完结
Olutasidenib alone or with azacitidine in IDH1-mutated acute myeloid leukaemia and myelodysplastic syndrome: phase 1 results of a phase 1/2 trial
10个月前
已完结
A Phase 1/2 Study of the Oral Janus Kinase 1 Inhibitors INCB052793 and Itacitinib Alone or in Combination With Standard Therapies for Advanced Hematologic Malignancies
10个月前
已完结
Somatic mutations in acquired pure red cell aplasia
10个月前
已完结
Gene mutations in bone marrow failure syndromes
1年前
已关闭
皖公网安备34019202002308
